CytoDyn Inc.
CYDY · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Hoffman Robert E.: Form 4
Insider disclosure · Filed · Report period 20 Oct 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CYDY · 23283M101 - Common Stock
Company details and SEC sources
CIK 0001175680 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CYDY on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1111 Main Street, Suite 660, Vancouver, WA, 98660
- Incorporated in
- DE
- Fiscal year end
- 31 May
- Former names on EDGAR
- REXRAY CORP (to 12 Nov 2003)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields